MARKET

SLP

SLP

Simulations Plus Inc
NASDAQ
39.97
+0.41
+1.04%
Opening 13:41 01/30 EST
OPEN
39.25
PREV CLOSE
39.56
HIGH
40.27
LOW
38.99
VOLUME
42.57K
TURNOVER
1.18M
52 WEEK HIGH
67.59
52 WEEK LOW
32.53
MARKET CAP
812.57M
P/E (TTM)
77.57
1D
5D
1M
3M
1Y
5Y
Sector Update: Health Care Stocks Trim Early Declines
Sector Update: Health Care Stocks Trim Early Declines
MT Newswires · 01/12 16:12
Sector Update: Health Care Stocks Slipping in Recent Trading
Sector Update: Health Care Stocks Slipping in Recent Trading
MT Newswires · 01/12 14:52
Simulations Plus executes $20M accelerated buyback
Seeking Alpha · 01/12 07:35
Reported Late Wednesday, Simulations Plus Executes $20M Accelerated Share Repurchase Agreement; The ASR Agreement Is Part Of The $50M Share Repurchase Program Authorized By The Board Of Directors On December 29, 2022
Benzinga · 01/12 05:38
Simulations Plus Enters Into Accelerated Share Repurchase Agreement to Buy Back $20 Million Common Shares
Simulations Plus Enters Into Accelerated Share Repurchase Agreement to Buy Back $20 Million Common Shares
MT Newswires · 01/12 04:32
BRIEF-Simulations Plus Executes $20 Mln Accelerated Share Repurchase Agreement
Reuters · 01/11 23:28
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga · 01/05 18:01
Constellation Brands, Walgreens, RPM International And Some Other Big Stocks Moving Lower On Thursday
Benzinga · 01/05 16:13
More
About SLP
Simulations Plus, Inc. is a developer of drug discovery and development software for mechanistic modeling and simulation, for machine-learning-based prediction of properties of molecules from their structure, and is exploring the application of its machine-learning technologies in other industries, including aerospace/military and general healthcare. The Company offers its products and services through two business segments, which include Simulations Plus, Inc. and Cognigen Corporation. Cognigen Corporation is the subsidiary of the Company. Its pharmaceutical/chemistry software is used by various companies, such as pharmaceutical, biotechnology, agrochemical, and food industry companies and to regulatory agencies for use in the conduct of industry-based research. Its clinical-pharmacology-based consulting services include pharmacokinetic and pharmacodynamics modeling, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions.

Webull offers kinds of Simulations Plus Inc stock information, including NASDAQ:SLP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SLP stock methods without spending real money on the virtual paper trading platform.